189 related articles for article (PubMed ID: 6224436)
1. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
Hofman FM; Meyer PR; Yanagihara E; Modlin RL; Rea TH; Parker JW; Lukes RJ; Taylor CR
Am J Dermatopathol; 1983 Apr; 5(2):135-43. PubMed ID: 6224436
[TBL] [Abstract][Full Text] [Related]
2. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
Thivolet J; Schmitt D; Souteyrand P; Brochier J
Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
[TBL] [Abstract][Full Text] [Related]
4. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome.
Piepkorn M; Marty J; Kjeldsberg CR
J Am Acad Dermatol; 1984 Sep; 11(3):427-32. PubMed ID: 6237132
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
6. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
[TBL] [Abstract][Full Text] [Related]
7. Disseminated pagetoid reticulosis associated with mycosis fungoides: immunomorphologic study.
Lacour JP; Juhlin L; el Baze P; Barety M; Ortonne JP
J Am Acad Dermatol; 1986 May; 14(5 Pt 2):898-901. PubMed ID: 2940272
[TBL] [Abstract][Full Text] [Related]
8. The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes.
Piepkorn M; Tigelaar RE
J Invest Dermatol; 1984 Oct; 83(4):281-5. PubMed ID: 6237158
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM
Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804
[TBL] [Abstract][Full Text] [Related]
10. Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome.
Meissner K; Löning T; Heckmayr M; Zschaber R; Jänner M
Arch Dermatol Res; 1983; 275(3):168-74. PubMed ID: 6351762
[TBL] [Abstract][Full Text] [Related]
11. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases.
Maeda K; Takahashi M; Takatsuka N; Miyazawa H
J Dermatol; 1990 Apr; 17(4):226-34. PubMed ID: 2195088
[TBL] [Abstract][Full Text] [Related]
14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
15. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.
Pulitzer MP; Horna P; Almeida J
Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521
[TBL] [Abstract][Full Text] [Related]
16. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
Furue M; Kadono T
J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
18. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell.
Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS
Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861
[TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides/Sezary's syndrome progressing to immunoblastic sarcoma. A T-cell lymphoproliferation with both helper and suppressor phenotypes.
Yanagihara ET; Parker JW; Meyer PR; Cain MJ; Hofman F; Lukes RJ
Am J Clin Pathol; 1984 Feb; 81(2):249-57. PubMed ID: 6230003
[TBL] [Abstract][Full Text] [Related]
20. Immunoelectron microscopy related to T-cell monoclonal surface antigen in mycosis fungoides.
Hashimoto K; Iwahara K
Am J Dermatopathol; 1983 Apr; 5(2):129-34. PubMed ID: 6224435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
